Hadi Falahatpisheh

Company: ALX Oncology Inc.

Job title: Vice President - Research & Development

Seminars:

Design Considerations for Optimizing Pharmacokinetic Profiles in Novel Conjugated Drugs 1:02 pm

Achieving a desirable efficacy and toxicity profile can be crucial for dose optimization, costeffectiveness and can ultimately determine whether a novel conjugate drug is worth investing in. This workshop will delve into how novel formats—such as peptide drug conjugates (PDCs) or bispecific ADCs, or novel payloads with different mechanism of actions, such as antibody degrader…Read more

day: Pre-Conference Workshop Day